Literature DB >> 5905083

Myotonia, procaine amide, and lupus-like syndrome.

L D Prockop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5905083     DOI： 10.1001/archneur.1966.00470090098014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  6 in total

1.  Procainamide-induced systemic lupus erythematosus.

Authors:  P J Sheldon; W R Williams
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

2.  Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.

Authors:  T P Anastassiades; J A Miliiken
Journal:  Can Med Assoc J       Date:  1972-08-19       Impact factor: 8.262

3.  Natural antibodies to procaine amide.

Authors:  A S Russell; M Ziff
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

4.  Lupus-like syndrome induced by procainamide.

Authors:  D G McDevitt; J F Glascow
Journal:  Br Med J       Date:  1967-09-23

5.  Myotonic dystrophy and multiple sclerosis.

Authors:  C F Terrence
Journal:  J Neurol       Date:  1976-10-04       Impact factor: 4.849

6.  Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1).

Authors:  Sylvia Nieuwenhuis; Joanna Widomska; Paul Blom; Peter-Bram A C 't Hoen; Baziel G M van Engelen; Jeffrey C Glennon
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.